NCT05489237
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05489237
Title First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors IDRX, Inc., a wholly owned subsidiary of GSK, LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | ITA | GBR | FRA | ESP | DEU | BEL

Facility Status City State Zip Country Details
GSK Investigational Site Miami Florida 33136 United States Details
GSK Investigational Site Chicago Illinois 60611 United States Details
GSK Investigational Site Boston Massachusetts 02215 United States Details
GSK Investigational Site St Louis Missouri 63129 United States Details
GSK Investigational Site New York New York 10065 United States Details
GSK Investigational Site Portland Oregon 97239 United States Details
GSK Investigational Site Philadelphia Pennsylvania 19111 United States Details
GSK Investigational Site Houston Texas 77030 United States Details
GSK Investigational Site Leuven 3000 Belgium Details
GSK Investigational Site Beijing 100142 China Details
GSK Investigational Site Guangzhou China Details
GSK Investigational Site Wuhan 430022 China Details
GSK Investigational Site Bordeaux 33076 France Details
GSK Investigational Site Lyon France Details
GSK Investigational Site Marseille 13005 France Details
GSK Investigational Site Villejuif 94805 France Details
GSK Investigational Site Berlin Germany Details
GSK Investigational Site Essen 45122 Germany Details
GSK Investigational Site Milan 20133 Italy Details
GSK Investigational Site Chiba 277-8577 Japan Details
GSK Investigational Site Kanagawa 247-8533 Japan Details
GSK Investigational Site Tokyo 104-0045 Japan Details
GSK Investigational Site Amsterdam 1066 CX Netherlands Details
GSK Investigational Site Rotterdam 3075 EA Netherlands Details
GSK Investigational Site Seongnam-si Gyeonggi-do 463-707 South Korea Details
GSK Investigational Site Seoul 120-752 South Korea Details
GSK Investigational Site Seoul 5505 South Korea Details
GSK Investigational Site Seoul 6351 South Korea Details
GSK Investigational Site Barcelona Spain Details
GSK Investigational Site Leeds LS9 7TF United Kingdom Details
GSK Investigational Site London SW3 6JJ United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field